Influenza A virus subtype H7N1
Influenza A virus subtype H7N1 is a subtype of the Influenza A virus that can cause illness in humans and many other animal species. A bird-adapted strain of H7N1 is considered endemic in domestic poultry. The dominant strain of H7N1 is found in birds, with a small percentage found in humans.
Overview[edit]
The Influenza A virus is a major pathogen in birds, humans, and other animals. The virus is classified into subtypes based on two surface proteins: Hemagglutinin (H) and Neuraminidase (N). The H7N1 subtype is one of many possible combinations of these two proteins.
Infection in Birds[edit]
H7N1 is highly pathogenic in birds. The virus was first identified in Italy in 1999, where it caused a significant outbreak in poultry. The virus is spread through direct contact with infected birds, and indirectly from the environment. Infected birds shed the virus in their saliva, nasal secretions, and feces.
Infection in Humans[edit]
Human infections with H7N1 are rare, but have been reported. Symptoms are similar to other types of flu and include fever, cough, sore throat, and muscle aches. In severe cases, infection can lead to pneumonia and other complications.
Prevention and Control[edit]
Vaccination is the most effective way to prevent infection. However, because the virus can mutate rapidly, vaccines must be updated regularly. Control measures in poultry include culling infected flocks, disinfecting premises, and implementing biosecurity measures.
See Also[edit]
| Influenza | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian